Cargando…

Skeletal abnormalities detected by SPECT is associated with increased relapse risk in pediatric acute lymphoblastic leukemia

OBJECTIVES: Most children with acute lymphoblastic leukemia (ALL) exhibit skeletal abnormalities. This study aimed to investigate bone lesions detected by whole-body bone single-photon emission computed tomography (SPECT) and its prognostic value in children with ALL. METHODS: A retrospective analys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Fen, Zhang, Meiling, Han, Juan, Hao, Jinjin, Xiao, Yan, Liu, Qin, Jin, Runming, Mei, Heng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668046/ https://www.ncbi.nlm.nih.gov/pubmed/29108313 http://dx.doi.org/10.18632/oncotarget.18110

Ejemplares similares

Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era
por: Mengxuan, Shang, et al.
Publicado: (2022)

The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia
por: Shen, Yaqing, et al.
Publicado: (2021)

Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia
por: Xu, Huan, et al.
Publicado: (2021)

Clinical characteristics and risk factors of acute lymphoblastic leukemia in children with severe infection during maintenance treatment
por: Yin, Tiantian, et al.
Publicado: (2023)

Risk Factors for Relapse of Childhood B Cell Acute Lymphoblastic Leukemia
por: Zhang, Rongrong, et al.
Publicado: (2020)

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
por: Bhojwani, Deepa, et al.
Publicado: (2018)

Humanized CD19-directed CAR-T Cell Therapy in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia With CNSL or Neurological Comorbidity
por: Zhang, Na, et al.
Publicado: (2022)

Case Report: Diffuse Large B Cell Lymphoma After Cardiac Transplantation due to Anthracycline-Induced Dilated Cardiomyopathy in Pediatric Acute Lymphoblastic Leukemia
por: Xin, Ning, et al.
Publicado: (2022)

Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis
por: Locatelli, Franco, et al.
Publicado: (2022)

Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial
por: Laetsch, Theodore W., et al.
Publicado: (2023)

Testicular relapse of acute lymphoblastic leukemia()
por: Carolan, Alexandra, et al.
Publicado: (2023)

Unilateral optic nerve infiltration as an initial site of relapse of acute lymphoblastic leukemia in remission
por: Bandyopadhyay, Sabyasachi, et al.
Publicado: (2010)

Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia
por: Bhojwani, Deepa, et al.
Publicado: (2019)

Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia
por: Verneris, Michael R., et al.
Publicado: (2021)

Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia
por: Wang, Han, et al.
Publicado: (2023)

Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia
por: Shimony, Shai, et al.
Publicado: (2022)

Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemia
por: Ryba, Tyrone, et al.
Publicado: (2012)

FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia
por: Yu, Sung-Liang, et al.
Publicado: (2020)

Malignant DFFB isoform switching promotes leukemia survival in relapse pediatric T‐cell acute lymphoblastic leukemia
por: Enlund, Sabina, et al.
Publicado: (2022)

Clinical characteristics and prognosis of pediatric patients with B cell acute lymphoblastic leukemia relapse
por: Zhang, Xiaohong, et al.
Publicado: (2018)

Nucleotide excision repair is a predictor of early relapse in pediatric acute lymphoblastic leukemia
por: Ibrahim, Omar M., et al.
Publicado: (2018)

Rapid resolution of bone marrow necrosis mimicking relapse of pediatric acute lymphoblastic leukemia
por: Lee, Jae Wook, et al.
Publicado: (2020)

Mutational patterns and clonal evolution from diagnosis to relapse in pediatric acute lymphoblastic leukemia
por: Sayyab, Shumaila, et al.
Publicado: (2021)

Targeted Treatment and Immunotherapy in High-risk and Relapsed/Refractory Pediatric Acute Lymphoblastic Leukemia
por: Graiqevci-Uka, Violeta, et al.
Publicado: (2022)

Pericardial Relapse of Acute Lymphoblastic Leukemia (ALL)
por: Maslov, Diana V., et al.
Publicado: (2021)

Outcomes of relapsed B-cell acute lymphoblastic leukemia after sequential treatment with blinatumomab and inotuzumab
por: Wudhikarn, Kitsada, et al.
Publicado: (2022)

Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma
por: Thudium Mueller, Karen, et al.
Publicado: (2021)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

A Retrospective Cytogenetic Abnormality in Pediatric Acute Lymphoblastic Leukemia: Report of 11 Years
por: Ghaffari, Kazem, et al.
Publicado: (2022)

Genetic abnormalities associated with acute lymphoblastic leukemia
por: Yokota, Takafumi, et al.
Publicado: (2016)

Intracranial Hemorrhage Following Oral Low-Dose Methotrexate After Multiple Toxicities Caused by High-Dose Methotrexate in Childhood Acute Lymphoblastic Leukemia
por: Xin, Ning, et al.
Publicado: (2019)

MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia
por: Evensen, Nikki A., et al.
Publicado: (2018)

Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia
por: Richter-Pechańska, P, et al.
Publicado: (2017)

Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia
por: Sági, Judit C., et al.
Publicado: (2021)

A novel BCR-ABL1 fusion gene with genetic heterogeneity indicates a good prognosis in a chronic myeloid leukemia case
por: Zhou, Fen, et al.
Publicado: (2017)

Abnormally high expression of POLD1, MCM2, and PLK4 promotes relapse of acute lymphoblastic leukemia
por: Li, Sheng, et al.
Publicado: (2018)

Optic nerve infiltration in relapse of acute lymphoblastic leukemia
por: Ali, Mohammad Javed, et al.
Publicado: (2011)

Erythroleukemia Relapsing as Precursor B-cell Lymphoblastic Leukemia
por: Park, Borae G., et al.
Publicado: (2011)

Optic nerve infiltration in relapse of acute lymphoblastic leukemia
por: Ali, Mohammad Javed, et al.
Publicado: (2011)

Mutational profiling of acute lymphoblastic leukemia with testicular relapse
por: Ding, Ling-Wen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_69lkbcb5e9dipu9hia7kpjqiu1